Technology overview: SonoVue (Bracco, Milan).
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15700328.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ultrasound contrast agents introduced to sonography the possibility to demonstrate microvascular organization and parenchymal perfusion. In combination with modern contrast-specific imaging modalities, contrast agent signals can be separated from tissue-derived signals, allowing the detection of extremely small quantities of contrast agent. The following article describes the physical principles for the creation of contrast-specific signals, the particular physicochemical characteristics of SonoVue, a second-generation ultrasound contrast agent, and the resulting possibilities for the assessment of physiological functions.
Medical subject headings
- Contrast Media
- Phospholipids
- Sulfur Hexafluoride
- Ultrasonography